,72,73,74 In human trials, chemotherapy combined with agonistic anti-CD40 has shown promising anti-tumor immune response in solid tumors such as melanoma,75 mesothelioma,76 and pancreatic cancer.75 Here, CD40 is linked to mesothelioma.